scispace - formally typeset
N

Niki Karavitaki

Researcher at University of Birmingham

Publications -  175
Citations -  7702

Niki Karavitaki is an academic researcher from University of Birmingham. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 40, co-authored 147 publications receiving 6071 citations. Previous affiliations of Niki Karavitaki include University Hospitals Birmingham NHS Foundation Trust & Queen Mary University of London.

Papers
More filters
Journal ArticleDOI

MANAGEMENT OF ENDOCRINE DISEASE: Visual morbidity in patients with pituitary adenoma.

TL;DR: Regular, full ophthalmic examination is an essential component of modern management of pituitary pathology at all time points of patient pathway, and well-designed studies minimising effects of bias and using tools and scoring systems reliably reflecting visual status will provide robust evidence on valid prognostication and patient stratification guiding clinical decision making.
Journal ArticleDOI

Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey.

TL;DR: In this paper , the authors used a cross-sectional, web-based, anonymous survey, developed by endocrinologists and patient representatives, to collect the opinions of patients with central diabetes insipidus on management and complications of their disease, psychological comorbidities, degree of knowledge and awareness of the condition among health-care professionals, and renaming the disease to avoid confusion with diabetes mellitus.
Journal ArticleDOI

Cushing's syndrome update: 100 years after Minnie G

TL;DR: Cushing's syndrome is still one of the most challenging disorders in the field of endocrinology and its management reflects a vast, scholarly and evocative landscape in studying the causes and mechanisms of excess hormones, as well as their consequences on the human body.
Journal ArticleDOI

Pituitary metastases: presentation and outcomes from a pituitary center over the last decade.

TL;DR: Clinical presentation of PM has evolved and is found to have increased prevalence of anterior hypopituitarism, decreased rates of DI and longer survival compared with older literature, increased availability of diagnostic imaging, improvements in screening and recognition of pituitary disease and longer survive of patients with metastatic cancer are contributing factors.